Compare

Propanc Biopharma, Inc. vs Nomad Power Solutions, Inc. vs Imunon, Inc. vs Turn Therapeutics Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearPropanc Biopharma, Inc.
PPCB
Nomad Power Solutions, Inc.
NMAD
Imunon, Inc.
IMNN
Turn Therapeutics Inc.
TTRX
Year ended2026-06-302025-12-312025-12-312025-12-31
Revenuen/an/an/an/a
Revenue growth (YoY)n/an/an/an/a
Gross marginn/an/an/an/a
Operating marginn/an/an/an/a
Net marginn/an/an/an/a
Net income-$18.86M-$6.08M-$14.50M-$3.19M
EPS (Diluted)-$17.62-$1.26-$6.83-$0.12
Operating cash flow-$5.68M-$3.07M-$13.90M-$2.56M
Free cash flow-$5.69Mn/a-$14.18Mn/a
Cash & equivalentsn/an/a$8.78M$4.03M
Total assets$12.78M$12.73M$12.29M$12.16M
Total liabilities$3.38M$1.77M$5.23M$7.48M
Shareholders' equity$9.40M$9.66M$7.06M$4.69M
Return on year-end equity-200.6%-62.9%-205.3%-68.2%
Shares outstanding3.31M8.79M3.42M29.45M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearPropanc Biopharma, Inc.Nomad Power Solutions, Inc.Imunon, Inc.Turn Therapeutics Inc.
Latestn/a$200.0K
Ended 2015-12-31
$500.0K
Ended 2022-12-31
n/a
1 year earliern/an/a$500.0K
Ended 2021-12-31
n/a
2 years earliern/a$0
Ended 2013-12-31
$500.0K
Ended 2020-12-31
n/a
3 years earliern/a$0
Ended 2012-12-31
$500.0K
Ended 2019-12-31
n/a
4 years earliern/a$0
Ended 2011-12-31
$500.0K
Ended 2018-12-31
n/a